Sarepta Therapeutics, Inc.
SRPT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $613 | $511 | $241 | $1,103 |
| Short-Term Investments | $238 | $290 | $282 | $252 |
| Receivables | $542 | $610 | $725 | $650 |
| Inventory | $1,077 | $994 | $941 | $750 |
| Other Curr. Assets | $253 | $253 | $244 | $319 |
| Total Curr. Assets | $2,722 | $2,657 | $2,433 | $3,073 |
| Property Plant & Equip (Net) | $498 | $515 | $508 | $489 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $30 | $31 | $26 | $27 |
| Long-Term Investments | $9 | $35 | $109 | $137 |
| Tax Assets | $2 | $0 | $0 | $0 |
| Other NC Assets | $232 | $443 | $390 | $237 |
| Total NC Assets | $771 | $1,023 | $1,033 | $890 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,493 | $3,680 | $3,465 | $3,963 |
| Liabilities | – | – | – | – |
| Payables | $94 | $137 | $156 | $214 |
| Short-Term Debt | $0 | $0 | $0 | $13 |
| Tax Payable | $0 | $19 | $80 | $17 |
| Deferred Revenue | $485 | $395 | $45 | $130 |
| Other Curr. Liab. | $342 | $369 | $325 | $356 |
| Total Curr. Liab. | $921 | $920 | $606 | $732 |
| LT Debt | $1,250 | $1,354 | $1,344 | $1,330 |
| Deferred Rev, NC | $0 | $0 | $325 | $325 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $49 | $48 | $49 |
| Total NC Liab. | $1,252 | $1,402 | $1,717 | $1,704 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $215 | $214 | $205 | $206 |
| Total Liabilities | $2,173 | $2,322 | $2,323 | $2,435 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$4,642 | -$4,462 | -$4,658 | -$4,211 |
| AOCI | $0 | -$0 | $0 | -$0 |
| Other Equity | $5,961 | $5,819 | $5,801 | $5,739 |
| Total Equity | $1,320 | $1,357 | $1,143 | $1,528 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,493 | $3,680 | $3,465 | $3,963 |
| Net Debt | $637 | $843 | $1,103 | $240 |